Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV and Tuberculosis Co-infection”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Not applicableUnknownNCT01687504
What this trial is testing

Pharmacokinetics of Anti-TB Drugs in HIV/TB Co-infected Children in Ghana

Who this might be right for
TuberculosisHIV
The Miriam Hospital 106
Post-approval studies (Phase 4)UnknownNCT04746547
What this trial is testing

Pharmacokinetics of Twice or Once Daily DTG (50mg) in Children With HIV and TB

Who this might be right for
TuberculosisHiv
University of KwaZulu 20
Post-approval studies (Phase 4)Study completedNCT00402454
What this trial is testing

Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis

Who this might be right for
HIV Infections
Sociedad Andaluza de Enfermedades Infecciosas 300
Large-scale testing (Phase 3)Study completedNCT02178592
What this trial is testing

Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 113
Testing effectiveness (Phase 2)Study completedNCT00651066
What this trial is testing

Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam

Who this might be right for
HIV InfectionsTuberculosis
French National Agency for Research on AIDS and Viral Hepatitis 47
Large-scale testing (Phase 3)Study completedNCT00483054
What this trial is testing

Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin

Who this might be right for
HIV InfectionsTuberculosis
Bamrasnaradura Infectious Diseases Institute 142
Post-approval studies (Phase 4)Study completedNCT01059422
What this trial is testing

Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients

Who this might be right for
HIV InfectionsTuberculosis
Central Institute of Epidemiology, Moscow, Russia 10
Not applicableStudy completedNCT04972903
What this trial is testing

Impact of Malnutrition on Pharmacokinetic of Rifampicin, Isoniazid, Pyrazinamide and Ethambutol in TB-HIV Co-infected Children (TB-Speed TB-PK)

Who this might be right for
TuberculosisPulmonary
Institut National de la Santé Et de la Recherche Médicale, France 85
Testing effectiveness (Phase 2)UnknownNCT00474435
What this trial is testing

Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis

Who this might be right for
TuberculosisHIV Infections
African Poverty Related Infection Oriented Research Initiative 30
Testing effectiveness (Phase 2)Study completedNCT02415985
What this trial is testing

Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly

Who this might be right for
HIVTuberculosis
The HIV Netherlands Australia Thailand Research Collaboration 40
Post-approval studies (Phase 4)Ended earlyNCT01014481
What this trial is testing

Appropriate Timing of HAART in Co-infected HIV/TB Patients

Who this might be right for
HIV InfectionsTuberculosis
Bamrasnaradura Infectious Diseases Institute 156
Not applicableLooking for participantsNCT05553236
What this trial is testing

Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis

Who this might be right for
Drug-resistant TuberculosisHIV CoinfectionCost-Benefit Analysis
University of California, San Francisco 2,500
Testing effectiveness (Phase 2)Study completedNCT00476853
What this trial is testing

Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy

Who this might be right for
HIV InfectionsTuberculosis
The HIV Netherlands Australia Thailand Research Collaboration 42
Not applicableActive Not RecruitingNCT02129244
What this trial is testing

A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection Outcomes

Who this might be right for
MDR-TBHIV
Johns Hopkins University 3,600
Not applicableStudy completedNCT03711721
What this trial is testing

Nutritional Support for HIV-Tuberculosis Co-infected Adults in Senegal, West Africa

Who this might be right for
HIV and Tuberculosis Co-infection
University of Washington 26
Testing effectiveness (Phase 2)Study completedNCT02412436
What this trial is testing

PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB

Who this might be right for
HIV-1 InfectionTuberculosis
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 62
Not applicableStudy completedNCT03800381
What this trial is testing

Adequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) Tablet

Who this might be right for
TuberculosisHuman Immunodeficiency VirusCoinfection
University of Florida 92
Large-scale testing (Phase 3)Study completedNCT01805258
What this trial is testing

Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin With HIV-TB

Who this might be right for
HIV/TB Co-infection
All India Institute of Medical Sciences 135
Large-scale testing (Phase 3)WithdrawnNCT00414414
What this trial is testing

A RCT of Prednisone as Adjunctive Therapy for Hospitalized Patients With Pulmonary TB and HIV Co-infection

Who this might be right for
TuberculosisHIV Infections
Ottawa Hospital Research Institute
Post-approval studies (Phase 4)UnknownNCT01782950
What this trial is testing

Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment Outcomes

Who this might be right for
AIDS With Tuberculosis
Makerere University 400
Next Page